Remission and time of resolution of nail psoriasis during infliximab therapy

被引：46

作者：

Bianchi, L ^{[1
]}

Bergamin, A ^{[1
]}

de Felice, C ^{[1
]}

Capriotti, E ^{[1
]}

Chimenti, S ^{[1
]}

机构：

[1] Univ Roma Tor Vergata, Dept Dermatol, I-00133 Rome, Italy

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2005年 / 52卷 / 04期

关键词：

D O I：

10.1016/j.jaad.2004.09.012

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：736 / 737

页数：2

共 5 条

[1] Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial [J].

Chaudhari, U ;

Romano, P ;

Mulcahy, LD ;

Dooley, LT ;

Baker, DG ;

Gottlieb, AB .

LANCET, 2001, 357 (9271) :1842-1847

[2] Management of nail psoriasis [J].

de Berker, D .

CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2000, 25 (05) :357-362

[3] Psoriasis of the nails associated with disability in a large number of patients: Results of a recent interview with 1,728 patients [J].

deJong, EMGJ ;

Seegers, BAMPA ;

Gulinck, MK ;

Boezeman, JBM ;

vandeKerkhof, PCM .

DERMATOLOGY, 1996, 193 (04) :300-303

[4] Pharmacodynamic and pharmacokinetic response to anti-tumor necrosis factor-α monoclonal antibody (infliximab) treatment of moderate to severe psoriasis vulgaris [J].

Gottlieb, AB ;

Masud, S ;

Ramamurthi, R ;

Abdulghani, A ;

Romano, P ;

Chaudhari, U ;

Dooley, LT ;

Fasanmade, AA ;

Wagner, CL .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 48 (01) :68-75

[5] Nail Psoriasis Severity Index: A useful tool for evaluation of nail psoriasis [J].

Rich, P ;

Scher, RK .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 49 (02) :206-212

← 1 →